BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36266768)

  • 1. Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis B.
    Kam LY; Huang DQ; Tobias AF; Poon K; Henry L; Kwo P; Cheung R; Nguyen MH
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1591-1601. PubMed ID: 36266768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination.
    Wong RJ; Kaufman HW; Niles JK; Kapoor H; Gish RG
    Clin Infect Dis; 2023 Feb; 76(3):e791-e800. PubMed ID: 35594550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantial gaps in evaluation and treatment of patients with hepatitis B in the US.
    Ye Q; Kam LY; Yeo YH; Dang N; Huang DQ; Cheung R; Nguyen MH
    J Hepatol; 2022 Jan; 76(1):63-74. PubMed ID: 34474097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.
    Pan CQ; Chan S; Trinh H; Yao A; Bae H; Lou L
    World J Gastroenterol; 2015 May; 21(18):5524-31. PubMed ID: 25987775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
    Uribe LA; Nguyen N; Kim L; Trinh HN; Wong C; Wong C; Nguyen LH; Nguyen MH
    Dig Dis Sci; 2016 Feb; 61(2):618-25. PubMed ID: 26660679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
    Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU
    Clin Mol Hepatol; 2014 Dec; 20(4):355-60. PubMed ID: 25548741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapy.
    Fung J; Seto WK; Lai CL; Yuen J; Wong DK; Yuen MF
    J Hepatol; 2011 Feb; 54(2):195-200. PubMed ID: 21056499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study.
    Hamida ME; Raja SM; Seyoum Y; Elkhidir IM; Tekle F
    BMC Gastroenterol; 2021 May; 21(1):198. PubMed ID: 33933017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B.
    Huang DQ; Lee DH; Le MH; Le A; Yeo YH; Trinh HN; Chung M; Nguyen V; Johnson T; Zhang JQ; Wong C; Wong C; Li J; Cheung R; Nguyen MH
    Dig Dis; 2023; 41(1):115-123. PubMed ID: 36070707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and management of patients with chronic hepatitis B in an integrated care setting.
    Sarkar M; Shvachko VA; Ready JB; Pauly MP; Terrault NA; Peters MG; Manos MM
    Dig Dis Sci; 2014 Sep; 59(9):2100-8. PubMed ID: 24728968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N; Xu JH; Yu M; Wang S; Si CW; Yu YY
    World J Gastroenterol; 2015 Nov; 21(43):12421-9. PubMed ID: 26604649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study.
    Zhang S; Ristau JT; Trinh HN; Garcia RT; Nguyen HA; Nguyen MH
    Dig Dis Sci; 2012 May; 57(5):1373-83. PubMed ID: 22466077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.
    Juday T; Tang H; Harris M; Powers AZ; Kim E; Hanna GJ
    J Gen Intern Med; 2011 Mar; 26(3):239-44. PubMed ID: 20978862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study.
    Wei S; Hu M; Chen H; Xie Q; Wang P; Li H; Peng J
    BMC Gastroenterol; 2022 Aug; 22(1):387. PubMed ID: 35978283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients.
    Ono A; Suzuki F; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Saitou S; Arase Y; Ikeda K; Kobayashi M; Watahiki S; Mineta R; Kumada H
    J Hepatol; 2012 Sep; 57(3):508-14. PubMed ID: 22659518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NICE guidelines and a treatment algorithm for the management of chronic hepatitis B: a review of 12 years experience in west London.
    Kennedy PT; Lee HC; Jeyalingam L; Malik R; Karayiannis P; Muir D; Main J; Thursz M; Goldin R; Smith B; Brown A; Thomas HC
    Antivir Ther; 2008; 13(8):1067-76. PubMed ID: 19195332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.
    Lee HM; Ahn J; Kim WR; Lim JK; Nguyen M; Pan CQ; Kim D; Mannalithara A; Te H; Trinh H; Chu D; Tran T; Woog J; Lok AS
    Dig Dis Sci; 2019 Feb; 64(2):358-366. PubMed ID: 30238203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.